Company profile
Revolution Medicines, Inc. insider acquisitions
Company CIK 0001628171 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
15 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Sep 29, 2026 | Revolution Medicines, Inc.Common Stock | Sandler Alan B. | Exercise / conversion |
| Nov 25, 2025 | Revolution Medicines, Inc.Common Stock | Anders Jack | Exercise / conversion |
| Nov 25, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Exercise / conversion |
| Nov 18, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Exercise / conversion |
| Nov 18, 2025 | Revolution Medicines, Inc.Common Stock | Cislini Jeff | Exercise / conversion |
| Nov 12, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Exercise / conversion |
| Nov 11, 2025 | Revolution Medicines, Inc.Common Stock | Anders Jack | Exercise / conversion |
| Nov 12, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Gift received |
| Nov 12, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Gift received |
| Nov 7, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Exercise / conversion |
| Nov 7, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Exercise / conversion |
| Oct 17, 2025 | Revolution Medicines, Inc.Common Stock | Cislini Jeff | Exercise / conversion |
| Oct 17, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Exercise / conversion |
| Oct 16, 2025 | Revolution Medicines, Inc.Common Stock | GOLDSMITH MARK A | Exercise / conversion |
| Oct 13, 2025 | Revolution Medicines, Inc.Common Stock | Kelsey Stephen Michael | Exercise / conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Choose a company listing
Choose a current company listing to view its price history.
Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Sandler Alan B.Chief Development Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 6,000 | 58.84Value: 353,040Currency not specified | View ↗ |
| Trade: | Anders JackChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 5,418 | 17Value: 92,106Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 60,000 | 4.09Value: 245,400Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 4.09Value: 81,800Currency not specified | View ↗ |
| Trade: | Cislini JeffGeneral Counsel | Exercise / conversionCommon StockNon-derivative security · Code M | 13,388 | 42.45Value: 568,320.6Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 20,000 | 4.09Value: 81,800Currency not specified | View ↗ |
| Trade: | Anders JackChief Financial Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 10,000 | 17Value: 170,000Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Gift receivedCommon StockNon-derivative security · Code G | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Gift receivedCommon StockNon-derivative security · Code G | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 3,521 | 4.09Value: 14,400.89Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 26,479 | 1.12Value: 29,656.48Currency not specified | View ↗ |
| Trade: | Cislini JeffGeneral Counsel | Exercise / conversionCommon StockNon-derivative security · Code M | 12,000 | 36.57Value: 438,840Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 10,000 | 1.12Value: 11,200Currency not specified | View ↗ |
| Trade: | GOLDSMITH MARK ASee Remarks · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 10,000 | 1.12Value: 11,200Currency not specified | View ↗ |
| Trade: | Kelsey Stephen MichaelSee Remarks | Exercise / conversionCommon StockNon-derivative security · Code M | 25,000 | 4.73Value: 118,250Currency not specified | View ↗ |
15 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →